Enteric Disease Testing Market, By Disease Type (E. coli Infection, Salmonellosis, Campylobacteriosis, Rotavirus Infection, Cryptosporidiosis, Norovirus Infection, Cholera, C. difficile, H. pylori, Amebiasis, Shigellosis), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Aug 2020

Code : CMI1164

Pages :145

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Enteric Disease Testing MarketSize and Trends

Statistics:

The global enteric disease testing market is estimated to account for US$ 4,432.7 Mn in terms of value by the end of 2027.

Statistics:

North America held dominant position in the global enteric disease testing market in 2019, accounting for 38.5% share in terms of value, followed by Europe and Asia Pacific, respectively.

Statistics:

The global enteric disease testing market was valued at US$ 3,643.4 Mn in 2019 and is forecast to reach a value of US$ 4,432.7 Mn by 2027 at a CAGR of 2.5% between 2020 and 2027.

Figure 2: Global Enteric Disease Testing Market Value (US$ Mn), 2016 – 2027

Market Trends/Key Takeaways

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2019, Mobidiag Ltd., a molecular diagnostics company, received CE marking for its Novodiag Stool Parasites test. The new test is used for the detection of intestinal parasites directly from stool samples.

Outbreak of campylobacter infection is expected to propel growth of the global enteric disease testing market. For instance, in August 2020, Lindsay Farm, New Zealand, recalled raw drinking milk in New Zealand after one person needed hospital treatment for a Campylobacter infection.